Nanalysis Scientific (TSE:NSCI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanalysis Scientific Corp. and the United States Pharmacopeia have co-published a study demonstrating the effectiveness of benchtop NMR technology for quality control in pharmaceuticals. The study highlights the advantages of this portable NMR solution, including faster measurements and reduced solvent usage, making it an accessible and scalable option for the industry. This advancement positions Nanalysis Scientific to potentially drive growth in pharmaceutical quality assurance globally.
For further insights into TSE:NSCI stock, check out TipRanks’ Stock Analysis page.